Green Alpha Advisors’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Green Alpha Advisors’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-47,647	Closed	-$35.5K	–	148
2024 Q4	$35.5K	Sell	47,647 -14,914	-24%	-$14.9K	0.03%	146
2024 Q3	$76.3K	Buy	+62,561	New	+$99.6K	0.06%	138

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Green Alpha Advisors's OMGA Position: Q1 2025 in Review

Green Alpha Advisors sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 47,647 shares — an estimated $35.5K sold.

Green Alpha Advisors first reported a position in OMGA in Q3 2024 and held it in 2 quarters. The position peaked at $76.3K in Q3 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Green Alpha Advisors reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Green Alpha Advisors sold 47,647 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $35.5K.
Green Alpha Advisors first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
Green Alpha Advisors's Omega Therapeutics, Inc. Common Stock position peaked at $76.3K in Q3 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Green Alpha Advisors's 13F filing for Q1 2025, filed 9 Apr 2025.